Integra LifeSciences Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Integra LifeSciences (IART) Tops Q3 EPS by 14c
November 2, 2021 6:12 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.86, $0.14 better than the analyst estimate of $0.72. Revenue for the quarter came in at $386.9 million versus the consensus estimate of $384.58 million.
GUIDANCE:
Integra LifeSciences sees FY2021 EPS of $3.16-$3.20, versus the consensus of $3.04.... More
